Literature DB >> 10215397

Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Influences of progenitor enrichment, interference with feeder layers, early-acting cytokines and agitation of culture vessels.

T Köhler1, R Plettig, W Wetzstein, B Schaffer, R Ordemann, H O Nagels, G Ehninger, M Bornhäuser.   

Abstract

Ex vivo expansion of human umbilical cord blood cells (HUCBC) is explored by several investigators to enhance the repopulating potential of HUCBC. We performed experiments using either Ficoll-separated or CD34+-selected HUCBC from the same donation in serum-free medium. CD34-purified HUCBC were cultured on either human umbilical vein endothelial cells (HUVEC) or irradiated bone marrow-derived stroma cells (BMSC) with addition of different cytokines. In addition, we tested the expansion of HUCBC in culture vessels with continuous rotation. CD34 enrichment led to a significant increase in the expansion factor of CD34+ cells compared with unmanipulated HUCBC. BMSC were more efficient in amplifying early progenitors than HUVEC. Optimum results were reached by a combination of SCF, FLT-3L at 300 ng/ml and IL-3 at 50 ng/ml. No significant improvement in the expansion of CD34+/38- primitive progenitors could be obtained with other combinations. Addition of megakaryocyte-derived growth and development factor to each growth factor cocktail improved the expansion results. Continuous rotation of culture vessels did not ameliorate the expansion rate of the analyzed subsets. Culture conditions separating stroma and HUCBC by a semipermeable membrane improved the expansion factors of CD34+, CD34+/38-, and CD34+/41+ cells and CFU-GM compared with contact cultures. These data might be useful when designing culture systems for clinical scale ex vivo expansion of HUCBC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10215397     DOI: 10.1002/stem.170019

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  10 in total

1.  Ex vivo expansion of human umbilical cord blood CD34+ cells in a collagen bead-containing 3-dimensional culture system.

Authors:  Han-Soo Kim; Jong Baeck Lim; Yoo Hong Min; Seung Tae Lee; Chuhl Joo Lyu; Eun Seok Kim; Hyun Ok Kim
Journal:  Int J Hematol       Date:  2003-08       Impact factor: 2.490

2.  The comparison of different protocols for expansion of umbilical-cord blood hematopoietic stem cells.

Authors:  Mihaela Chivu; Carmen C Diaconu; Coralia Bleotu; Irina Alexiu; Lorelei Brasoveanu; C Cernescu
Journal:  J Cell Mol Med       Date:  2004 Apr-Jun       Impact factor: 5.310

Review 3.  Wharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a Review.

Authors:  Melania Lo Iacono; Rita Anzalone; Giampiero La Rocca; Elena Baiamonte; Aurelio Maggio; Santina Acuto
Journal:  Stem Cell Rev Rep       Date:  2017-02       Impact factor: 5.739

Review 4.  Concise review: umbilical cord blood transplantation: past, present, and future.

Authors:  Javier Munoz; Nina Shah; Katayoun Rezvani; Chitra Hosing; Catherine M Bollard; Betul Oran; Amanda Olson; Uday Popat; Jeffrey Molldrem; Ian K McNiece; Elizabeth J Shpall
Journal:  Stem Cells Transl Med       Date:  2014-11-05       Impact factor: 6.940

Review 5.  Wnt signaling and the control of human stem cell fate.

Authors:  J K Van Camp; S Beckers; D Zegers; W Van Hul
Journal:  Stem Cell Rev Rep       Date:  2014-04       Impact factor: 5.739

6.  Thrombopoietin, flt3-ligand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133 cells.

Authors:  C P McGuckin; N Forraz; R Pettengell; A Thompson
Journal:  Cell Prolif       Date:  2004-08       Impact factor: 6.831

7.  Cell-cell interaction networks regulate blood stem and progenitor cell fate.

Authors:  Daniel C Kirouac; Gerard J Madlambayan; Mei Yu; Edward A Sykes; Caryn Ito; Peter W Zandstra
Journal:  Mol Syst Biol       Date:  2009-07-28       Impact factor: 11.429

8.  Effect of Subcultivation of Human Bone Marrow Mesenchymal Stem on their Capacities for Chondrogenesis, Supporting Hematopoiesis, and Telomea Length.

Authors:  Masaki Nakahara; Mutsumi Takagi; Takako Hattori; Shigeyuki Wakitani; Toshiomi Yoshida
Journal:  Cytotechnology       Date:  2005-01       Impact factor: 2.058

9.  Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.

Authors:  Qiuyang Li; Dewan Zhao; Qiang Chen; Maowen Luo; Jingcao Huang; Cao Yang; Fangfang Wang; Wenxian Li; Ting Liu
Journal:  Stem Cell Res Ther       Date:  2019-12-05       Impact factor: 6.832

10.  Co-culture with mesenchymal stromal cells increases proliferation and maintenance of haematopoietic progenitor cells.

Authors:  Thomas Walenda; Simone Bork; Patrick Horn; Frederik Wein; Rainer Saffrich; Anke Diehlmann; Volker Eckstein; Anthony D Ho; Wolfgang Wagner
Journal:  J Cell Mol Med       Date:  2009-05-11       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.